NEW YORK (GenomeWeb News) – Horizon Discover today said it has signed a licensing and distribution deal with the American Type Culture Collection for certain sets of panels of X-Man isogenic cell lines.
ATCC will provide to its academic and not-for-profit customers certain Horizon products as part of, or in conjunction with, ATCC's Tumor Cell Panels. The deal is for non-commercial use only and excludes distribution in Japan or distribution of X-Man isogenic cell lines in isolation.
Financial and other terms of the deal were not disclosed.
Horizon offers more than 450 X-Man cell lines, which it said are the world's first source of genetically defined and patient-relevant human cell lines.
"The ability to work with accurate disease model cell lines is of great benefit, particularly in oncology research where many mutations studied are rare, and reliable sources of patient-derived cell lines are scarce," ATCC CEO Raymond Cypess said in a statement.